140 related articles for article (PubMed ID: 2098296)
21. Chemoprophylaxis with oral ciprofloxacin in ovarian cancer patients receiving taxol.
Carlson JW; Fowler JM; Saltzman AK; Carter JR; Chen MD; Mitchell SK; Dunn D; Carson LF; Adcock LL; Twiggs LB
Gynecol Oncol; 1994 Dec; 55(3 Pt 1):415-20. PubMed ID: 7530677
[TBL] [Abstract][Full Text] [Related]
22. Comparative trial of ketoconazole and nystatin for prevention of fungal infection in neutropenic patients treated in a protective environment.
Shepp DH; Klosterman A; Siegel MS; Meyers JD
J Infect Dis; 1985 Dec; 152(6):1257-63. PubMed ID: 3905986
[TBL] [Abstract][Full Text] [Related]
23. Selective bowel decontamination for the prevention of infection in acute myelogenous leukemia: a prospective randomized trial.
Lee DG; Choi SM; Choi JH; Yoo JH; Park YH; Kim YJ; Lee S; Min CK; Kim HJ; Kim DW; Lee JW; Min WS; Shin WS; Kim CC
Korean J Intern Med; 2002 Mar; 17(1):38-44. PubMed ID: 12014211
[TBL] [Abstract][Full Text] [Related]
24. Prevention of mycosis in granulocytopenic patients. A comparative study between nystatin and ketoconazole.
Avilés A; Ambríz R; Escobedo J; Sinco A; Pizzuto J; Macotela E
Arch Invest Med (Mex); 1984; 15(1):55-65. PubMed ID: 6089686
[No Abstract] [Full Text] [Related]
25. Ciprofloxacin prophylaxis in patients with acute leukemia and granulocytopenia in an area with a high prevalence of ciprofloxacin-resistant Escherichia coli.
Gomez L; Garau J; Estrada C; Marquez M; Dalmau D; Xercavins M; Martí JM; Estany C
Cancer; 2003 Jan; 97(2):419-24. PubMed ID: 12518366
[TBL] [Abstract][Full Text] [Related]
26. Nystatin prophylaxis of fungal colonization and infection in granulocytopenic patients: correlation of colonization and clinical outcome.
Buchanan AG; Riben PD; Rayner EN; Parker SE; Ronald AR; Louie TJ
Clin Invest Med; 1985; 8(2):139-47. PubMed ID: 3879598
[TBL] [Abstract][Full Text] [Related]
27. Prevention of bacterial and fungal infections in granulocytopenic patients.
Verhoef J; Rozenberg-Arska M; Dekker AW
Eur J Cancer Clin Oncol; 1989 Sep; 25(9):1345-50. PubMed ID: 2680513
[TBL] [Abstract][Full Text] [Related]
28. Infection prophylaxis in neutropenic patients with acute leukaemia--a randomized, comparative study with ofloxacin, ciprofloxacin and co-trimoxazole/colistin.
Arning M; Wolf HH; Aul C; Heyll A; Scharf RE; Scheider W
J Antimicrob Chemother; 1990 Nov; 26 Suppl D():137-42. PubMed ID: 2286588
[TBL] [Abstract][Full Text] [Related]
29. Ciprofloxacin for infection prevention in patients with acute leukemia.
Rozenberg-Arska M; Dekker AW
Pharm Weekbl Sci; 1987 Dec; 9 Suppl():S45-7. PubMed ID: 3325929
[TBL] [Abstract][Full Text] [Related]
30. Low morbidity and mortality from infection in neutropenic patients, a possible result of multiple measures of infection prevention.
Grob JP; Francioli P; Pécoud A; Glauser MP
Schweiz Med Wochenschr Suppl; 1983; 14():70-5. PubMed ID: 6581532
[TBL] [Abstract][Full Text] [Related]
31. Norfloxacin for prevention of bacterial infections in granulocytopenic patients.
Winston DJ; Ho WG; Champlin RE; Karp J; Bartlett J; Finley RS; Joshi JH; Talbot G; Levitt L; Deresinski S
Am J Med; 1987 Jun; 82(6B):40-6. PubMed ID: 3037899
[TBL] [Abstract][Full Text] [Related]
32. Prevention of infection in the neutropenic patient.
Verhoef J; Rozenberg-Arska M; Dekker A
Rev Infect Dis; 1989; 11 Suppl 7():S1545-50. PubMed ID: 2513630
[TBL] [Abstract][Full Text] [Related]
33. Infection prevention in severely myelosuppressed patients: a comparison between ciprofloxacin and a regimen of selective antibiotic modulation of the intestinal flora.
Jansen J; Cromer M; Akard L; Black JR; Wheat LJ; Allen SD
Am J Med; 1994 Apr; 96(4):335-41. PubMed ID: 8166152
[TBL] [Abstract][Full Text] [Related]
34. Amphotericin B vs high-dose ketoconazole for empirical antifungal therapy among febrile, granulocytopenic cancer patients. A prospective, randomized study.
Walsh TJ; Rubin M; Hathorn J; Gress J; Thaler M; Skelton J; McKnight J; Browne M; Marshall D; Cotton D
Arch Intern Med; 1991 Apr; 151(4):765-70. PubMed ID: 2012462
[TBL] [Abstract][Full Text] [Related]
35. [Evaluation of antibiotic prophylaxis in neutropenic patients with hematologic malignancies].
Delarive P; Baumgartner JD; Glauser MP; Cometta A
Schweiz Med Wochenschr; 2000 Dec; 130(48):1837-44. PubMed ID: 11132527
[TBL] [Abstract][Full Text] [Related]
36. Ciprofloxacin and norfloxacin for selective decontamination in patients with severe granulocytopenia.
Maschmeyer G; Haralambie E; Gaus W; Kern W; Dekker AW; De Vries-Hospers HG; Sizoo W; König W; Gutzler F; Daenen S
Infection; 1988; 16(2):98-104. PubMed ID: 3286509
[TBL] [Abstract][Full Text] [Related]
37. [Prevention of bacterial and fungal infections in neutropenic patients with malignant hematologic diseases].
Candoni A; Russo D; Salmaso F
Clin Ter; 1997; 148(1-2):23-8. PubMed ID: 9377834
[TBL] [Abstract][Full Text] [Related]
38. Symposium on infectious complications of neoplastic disease (Part II). Chemoprophylaxis of bacterial infections in granulocytopenic patients.
Henry SA
Am J Med; 1984 Apr; 76(4):645-51. PubMed ID: 6369979
[TBL] [Abstract][Full Text] [Related]
39. The granulocytopenic patient: another consideration for antimicrobial prophylaxis.
Otis LL; Terezhalmy GT
Oral Surg Oral Med Oral Pathol; 1985 Jul; 60(1):125-9. PubMed ID: 3162130
[TBL] [Abstract][Full Text] [Related]
40. Severe infections in children with acute leukemia undergoing intensive chemotherapy can successfully be prevented by ciprofloxacin, voriconazole, or micafungin prophylaxis.
Yeh TC; Liu HC; Hou JY; Chen KH; Huang TH; Chang CY; Liang DC
Cancer; 2014 Apr; 120(8):1255-62. PubMed ID: 24415457
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
